Ocular Therapeutix, Inc. (OCUL)
6.205
-0.08
(-1.19%)
USD |
NASDAQ |
Nov 13, 16:00
6.20
0.00 (0.00%)
After-Hours: 19:59
Ocular Therapeutix Price to Book Value : 3.094 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 3.132 |
| November 11, 2026 | 3.321 |
| November 10, 2026 | 3.296 |
| November 09, 2026 | 3.416 |
| November 06, 2026 | 3.289 |
| November 05, 2026 | 3.206 |
| November 04, 2026 | 3.560 |
| November 03, 2026 | 3.401 |
| November 02, 2026 | 3.356 |
| October 30, 2026 | 3.476 |
| October 29, 2026 | 3.645 |
| October 28, 2026 | 3.635 |
| October 27, 2026 | 3.351 |
| October 26, 2026 | 3.226 |
| October 23, 2026 | 3.241 |
| October 22, 2026 | 3.296 |
| October 21, 2026 | 3.231 |
| October 20, 2026 | 3.316 |
| October 19, 2026 | 3.137 |
| October 16, 2026 | 3.426 |
| October 15, 2026 | 3.680 |
| October 14, 2026 | 3.590 |
| October 13, 2026 | 3.610 |
| October 12, 2026 | 3.770 |
| October 09, 2026 | 3.760 |
| Date | Value |
|---|---|
| October 08, 2026 | 3.745 |
| October 07, 2026 | 3.605 |
| October 06, 2026 | 3.660 |
| October 05, 2026 | 3.615 |
| October 02, 2026 | 3.471 |
| October 01, 2026 | 3.635 |
| September 30, 2026 | 3.825 |
| September 29, 2026 | 3.323 |
| September 28, 2026 | 3.232 |
| September 25, 2026 | 4.075 |
| September 24, 2026 | 4.146 |
| September 23, 2026 | 4.222 |
| September 22, 2026 | 4.434 |
| September 21, 2026 | 4.218 |
| September 18, 2026 | 4.218 |
| September 17, 2026 | 4.282 |
| September 16, 2026 | 4.168 |
| September 15, 2026 | 4.303 |
| September 14, 2026 | 4.527 |
| September 11, 2026 | 4.429 |
| September 10, 2026 | 4.484 |
| September 09, 2026 | 4.843 |
| September 08, 2026 | 4.801 |
| September 04, 2026 | 4.493 |
| September 03, 2026 | 4.493 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| EyePoint, Inc. | 0.1583 |
| ANI Pharmaceuticals, Inc. | 2.569 |
| Eli Lilly & Co. | 33.76 |
| Corcept Therapeutics, Inc. | 9.570 |
| Veru, Inc. | 1.274 |
Price to Book Value Related Metrics
| PS Ratio | 27.63 |
| PEG Ratio | -3.156 |
| Price | 6.205 |
| Earnings Yield | -23.46% |
| Market Cap | 1.364B |
| PEGY Ratio | -3.156 |